Juli Miller | Senior Director, IR |
Adrian Rawcliffe | CEO |
Elliot Norry | Senior VP and Chief Medical Officer |
Helen Tayton-Martin | Co-Founder and Chief Business Officer |
John Lunger | Chief Patient Supply Officer |
Marc Frahm | Cowen and Company |
Tony Butler | ROTH Capital |
Mohit Bansal | Citigroup |
Kelsey Goodwin | Guggenheim Securities |
Nick Abbott | Wells Fargo Securities |
Jonathan Chang | SVB Leerink |
Gabriel Fung | Mizuho Securities |
Hello, and welcome to Adaptimmune Q2 Financial and Business Update. With me on today's call is Juli Miller. Juli, you may begin.
Good morning and welcome to Adaptimmune's conference call to discuss our second quarter 2020 financial results. I would ask you to please review the full text of our forward-looking statements from this morning's press release.